[Form 4] The Bancorp Inc. Insider Trading Activity

Rhea-AI Filing Summary

The Bancorp, Inc. (TBBK) director Cheryl Creuzot reported a sale of company stock. On 08/22/2025 she sold 837 shares of common stock at a reported price of $71.87 per share and, following that transaction, beneficially owned 9,214 shares held directly. The Form 4 was signed by an attorney-in-fact on 08/25/2025 and was filed by one reporting person.

Positive

• Insider transaction disclosed with date, quantity (837 shares), price ($71.87), and post-transaction ownership (9,214 shares)
• Reporting person identified as Director Cheryl Creuzot and filing executed/signed (attorney-in-fact signature dated 08/25/2025)

Negative

• Director disposed of shares (sale of 837 shares) which reduces her direct holding

Insights

Financial Analyst

TL;DR: Director sold a small number of shares; the transaction is disclosed and does not materially alter ownership.

The Form 4 shows a single non-derivative sale of 837 shares at $71.87 on 08/22/2025, leaving the reporting person with 9,214 shares directly beneficially owned. The absolute size of the sale is modest relative to the remaining holding reported, so this disclosure is primarily a routine insider transaction rather than a company-moving event. All relevant transaction details (date, quantity, price, and post-transaction ownership) are provided on the filing.

Corporate Governance Expert

TL;DR: Form 4 provides required transparency on insider disposal; no governance red flags in the filing itself.

The filing identifies Cheryl Creuzot as a director and reports a sale of 837 shares. The document is signed by an attorney-in-fact and indicates a single reporting person filed the form. The content contains the standard disclosure elements (security type, transaction code, price, and post-transaction ownership). The filing does not disclose any derivative transactions or other unusual arrangements.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Creuzot Cheryl

(Last) (First) (Middle)

C/O THE BANCORP, INC.

409 SILVERSIDE ROAD

(Street)

WILMINGTON DE 19809

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bancorp, Inc. [ TBBK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/22/2025		S		837	D	$71.87	9,214	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Martin Egan, as attorney-in-fact	08/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Cheryl Creuzot report for TBBK?

The Form 4 reports a sale of 837 shares of The Bancorp, Inc. common stock on 08/22/2025 at a reported price of $71.87 per share.

How many TBBK shares does Cheryl Creuzot beneficially own after the transaction?

Following the reported sale, Cheryl Creuzot beneficially owned 9,214 shares held directly.

What is the reporting person’s relationship to TBBK in the Form 4?

The filing identifies the reporting person as a Director of The Bancorp, Inc.

When was the Form 4 signed and by whom?

The Form 4 is signed by /s/ Martin Egan, as attorney-in-fact with a signature date of 08/25/2025.

Does the Form 4 report any derivative transactions for TBBK by the reporting person?

No. Table II for derivative securities contains no entries; only a non-derivative sale of common stock is reported.